Contribution of the Gag-Pol transframe domain p6* and its coding sequence to morphogenesis and replication of human immunodeficiency virus type 1

Virology

Volumn 330, Issue 1, 2004, Pages 271-283

  Paulus, Christina ^a   Ludwig, Christine ^a   Wagner, Ralf ^a,b  

^a Institute of Medical Microbiology and Hygiene   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Cleavage site; Frameshift; Gag Pol; HIV 1; Maturation; p6*; p6pol; Protease activation; Protease regulation; Transframe protein

Indexed keywords

AMINO ACID; GAG PROTEIN; PEPSINOGEN; PEPTIDE DERIVATIVE; POL PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR CLONING; MUTATION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROVIRUS; VIRUS INFECTION; VIRUS MORPHOGENESIS; VIRUS RECOMBINANT; VIRUS REPLICATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; ENZYME ACTIVATION; FRAMESHIFT MUTATION; FUSION PROTEINS, GAG-POL; HIV PROTEASE; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; MORPHOGENESIS; MUTAGENESIS, SITE-DIRECTED; PEPTIDE FRAGMENTS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 7444244966     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virol.2004.09.013     Document Type: Article

References (58)

1. Pol-protease fusion protein is present in mature particles of human immunodeficiency virus type 1 J. Virol. 70 1996 7228 7232
2. 1H-NMR spectra and structural characterization in solution of the HIV-1 transframe protein p6* Eur. J. Biochem. 237 1996 383 392
3. L. Bidou, G. Stahl, B. Grima, H. Liu, M. Cassan, and J.P. Rousset In vivo HIV-1 frameshifting efficiency is directly related to the stability of the stem-loop stimulatory signal RNA 3 1997 1153 1158
4. G. Bleiber, S. Peters, R. Martinez, D. Cmarko, P. Meylan, and A. Telenti The central region of human immunodeficiency virus type 1 p6 protein (Gag residues S14-I31) is dispensable for the virus in vitro J. Gen. Virol. 85 2004 921 927
5. I. Brierley Ribosomal frameshifting viral RNAs J. Gen. Virol. 76 1995 1885 1892
6. M. Cassan, N. Delaunay, C. Vaquero, and J. Rousset Translational frameshifting at the gag-pol junction of human immunodeficiency virus type 1 is not increased in infected T-lymphoid cells J. Virol. 68 1994 1501 1508
7. N. Chen, A. Morag, N. Almog, I. Blumenzweig, O. Dreazin, and M. Kotler Extended nucleocapsid protein is cleaved from the Gag-Pol precursor of human immunodeficiency virus type 1 J. Gen. Virol. 82 2001 581 590
8. E. Co, G. Koelsch, Y. Lin, E. Ido, J.A. Hartsuck, and J. Tang Proteolytic processing mechanisms of a miniprecursor of the aspartic protease of human immunodeficiency virus type 1 Biochemistry 33 1994 1248 1254
9. L.J. Costa, Y.-H. Zeng, J. Sabotic, J. Mak, O.T. Fackler, and B.M. Peterlin Nef binds p6* in GagPol during replication of human immunodeficiency virus type 1 J. Virol. 78 2004 5311 5323
10. M.O. Dayhoff, R. von Eck, and C.M. Park A model for evolutionary change in proteins M.O. Dayhoff Atlas of Protein Sequence and Structure vol. 5 1972 Natl. Biomed. Res. Found Washington, DC 89 99
11. M. Dettenhofer, and X.F. Yu Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins J. Virol. 73 1999 4696 4704
12. E.O. Freed HIV-1 gag proteins: diverse functions in the virus life cycle Virology 251 1998 1 15
13. E.O. Freed HIV-1 replication Somatic Cell Mol. Genet. 26 2001 13 33
14. T. Fujita, H. Shibuya, T. Ohashi, K. Yamanishi, and T. Taniguchi Regulation of human interleukin-2 gene: functional DNA sequences in the 5′ flanking region for the gene expression in activated T-lymphocytes Cell 46 1986 401 405
15. Göttlinger, H., 2001. HIV-1 Gag: a molecular machine driving viral particle assembly and release, HIV Database Review Articles.
16. F.L. Graham, and A.J. van der Eb A new technique for the assay of infectivity of human adenovirus 5 DNA Virology 52 1973 456 467
17. L.E. Henderson, M.A. Bowers, R.C. Sowder, S.A. Serabyn, D.G. Johnson, J.W. Bess, L.O. Arthur, D.K. Bryant, and C. Fenselau Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences J. Virol. 66 1992 1856 1865
18. S.N. Ho, H.D. Hunt, R.M. Horton, J.K. Pullen, and L.R. Pease Site-directed mutagenesis by overlap extension using the polymerase chain reaction Gene 77 1989 51 59
19. A. Honda, T. Nakamura, and S. Nishimura RNA signals for translation frameshift: influence of stem size and slippery sequence Biochem. Biophys. Res. Commun. 213 1995 575 582
20. T. Jacks, M.D. Power, F.R. Masiarz, P.A. Luciw, P.J. Barr, and H.E. Varmus Characterization of ribosomal frameshifting in HIV-1 gag-pol expression Nature 331 1988 280 283
21. A.H. Kaplan, and R. Swanstrom Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments Proc. Natl. Acad. Sci. U.S.A. 88 1991 4528 4532
22. I. Katoh, Y. Ikawa, and Y. Yoshinaka Retrovirus protease characterized as a dimeric aspartic proteinase J. Virol. 63 1989 2226 2232
23. R.A. Katz, and A.M. Skalka The retroviral enzymes Annu. Rev. Biochem. 63 1994 133 173
24. J. Kimpton, and M. Emerman Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene J. Virol. 66 1992 2232 2239
25. H. Kollmus, A. Honigman, A. Panet, and H. Hauser The sequences of and distance between two cis-acting signals determine the efficiency of ribosomal frameshifting in human immunodeficiency virus type 1 and human T-cell leukemia virus type II in vivo J. Virol. 68 1994 6087 6091
26. M. Kotler, G. Arad, and S.H. Hughes Human immunodeficiency virus type 1 gag-protease fusion proteins are enzymatically active J. Virol. 66 1992 6781 6783
27. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
28. gag-pol from human immunodeficiency virus type 1 (HIV) in acutely infected, cultured human T-lymphocytes Virology 214 1995 624 627
29. J.M. Louis, N.T. Nashed, K.D. Parris, A.R. Kimmel, and D.M. Jerina Kinetics and mechanism of autoprocessing of human immunodeficiency virus type 1 protease from an analog of the Gag-Pol polyprotein Proc. Natl. Acad. Sci. U.S.A. 91 1994 7970 7974
30. J.M. Louis, F. Dyda, N.T. Nashed, A.R. Kimmel, and D.R. Davies Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease Biochemistry 37 1998 2105 2110
31. J.M. Louis, G.M. Clore, and A.M. Gronenborn Autoprocessing of HIV-1 protease is tightly coupled to protein folding Nat. Struct. Biol. 6 1999 868 875
32. J.M. Louis, E.M. Wondrak, A.R. Kimmel, P.T. Wingfield, and N.T. Nashed Proteolytic processing of HIV-1 protease precursor, kinetics and mechanism J. Biol. Chem. 274 1999 23437 23442
33. T. Mitsudomi, S.M. Steinberg, M.M. Nau, D. Carbone, D. D'Amico, S. Bodner, H.K. Oie, R.I. Linnoila, J.L. Mulshine, J.D. Minna, and A.F. Gazdar p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features Oncogene 7 1992 171 180
34. M.V. Nermut, and D.J. Hockley Comparative morphology and structural classification of retroviruses Curr. Top. Microbiol. Immunol. 214 1996 1 24
35. T. Ono, Y. Iwatani, A. Nishimura, A. Ishimoto, and H. Sakai Functional association between the nef gene product and gag-pol region of HIV-1 FEBS Lett. 466 2000 233 238
36. N.T. Parkin, M. Chamorro, and H.E. Varmus Human immunodeficiency virus type 1 gag-pol frameshifting is dependent on downstream mRNA secondary structure: demonstration by expression in vivo J. Virol. 66 1992 5147 5151
37. K. Partin, G. Zybarth, L. Ehrlich, M. DeCrombrugghe, E. Wimmer, and C. Carter Deletion of sequences upstream of the proteinase improves the proteolytic processing of human immunodeficiency virus type 1 Proc. Natl. Acad. Sci. U.S.A. 88 1991 4776 4780
38. C. Paulus, S. Hellebrand, U. Tessmer, H. Wolf, H.-G. Kräusslich, and R. Wagner Competitive inhibition of immunodeficiency virus type-1 protease by the Gag-Pol transframe protein* J. Biol. Chem. 274 1999 21539 21543
39. S.C. Pettit, S. Gulnik, L. Everitt, and A.H. Kaplan The dimer interface of protease and extra-protease domains influence the activation of protease and the specificity of Gag-Pol cleavage J. Virol. 77 2003 366 374
40. L.H. Phylip, J.S. Mills, B.F. Parten, B.M. Dunn, and J. Kay Intrinsic activity of precursor forms of HIV-1 proteinase FEBS Lett. 314 1992 449 454
41. L. Ratner, A. Fisher, L.L. Jagodzinski, H. Mitsuya, R.S. Liou, R.C. Gallo, and F. Wong-Staal Complete nucleotide sequences of functional clones of the AIDS virus AIDS Res. Hum. Retroviruses 3 1987 57 69
42. H. Reil, and H. Hauser Test system for determination of HIV-1 frameshifting efficiency in animal cells Biochim. Biophys. Acta 1050 1990 288 292
43. H. Reil, H. Kollmus, U.H. Weidle, and H. Hauser A heptanucleotide sequence mediates ribosomal frameshifting in mammalian cells J. Virol. 67 1993 5579 5584
44. J.R. Rosé, L.M. Babé, and C.S. Craik Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity J. Virol. 69 1995 2751 2758
45. H. Schägger, and G. von Jagow Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa Anal. Biochem. 166 1987 368 379
46. I. Schechter, and A. Berger On the size of the active site in proteases: I. Papain Biochem. Biophys. Res. Commun. 27 1967 157 162
47. H.J. Schramm, A. Billich, E. Jaeger, K.-P. Rucknagel, G. Arnold, and W. Schramm The inhibition of HIV-1 protease by interface peptides Biochem. Biophys. Res. Commun. 194 1993 595 600
48. A. Telenti, R. Martinez, M. Munoz, G. Bleiber, G. Greub, D. Sanglard, and S. Peters Analysis of natural variants of the human immunodeficiency virus type 1 gag pol frameshift stem loop structure J. Virol. 76 2002 7868 7873
49. U. Tessmer, and H.-G. Kräusslich Cleavage of human immunodeficiency virus type 1 proteinase from the N terminally adjacent p6* protein is essential for efficient Gag polyprotein processing and viral infectivity J. Virol. 72 1998 3459 3463
50. H. Toh, M. Ono, K. Saigo, and T. Miyata Retroviral protease like sequence in the yeast transposon Ty 1 Nature 315 1985 691 692
51. Y.N. Vaishnav, and F. Wong-Staal The biochemistry of AIDS Annu. Rev. Biochem. 60 1991 577 630
52. V.M. Vogt Proteolytic processing and particle maturation Curr. Top. Microbiol. Immunol. 214 1996 95 131
53. W. Wilson, M. Braddock, S.E. Adams, P.D. Rathjen, S.M. Kingsman, and A.J. Kingsman HIV expression strategies: ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems Cell 55 1988 1159 1169
54. H. Wolf, S. Modrow, E. Soutschek, M. Motz, R. Grunow, H. Döbl, and R. von Baehr Production, mapping and biological characterization of monoclonal antibodies against core protein (p24) of the human immunodeficiency virus AIDS-Forsch. 1 1990 16 18
55. E.M. Wondrak, N.T. Nashed, M.T. Haber, D.M. Jerina, and J.M. Louis A transient precursor of the HIV 1 protease. Isolation, characterization, and kinetics of maturation J. Biol. Chem. 271 1996 4477 4481
56. Y.H. Zeng, A. Plemenitas, T. Linnemann, O.T. Fackler, and B.M. Peterlin Nef increases infectivity of HIV via lipid rafts Curr. Biol. 11 2001 875 879
57. G. Zybarth, and C. Carter Domains upstream of the protease (PR) in human immunodeficiency virus type 1 Gag Pol influence PR autoprocessing J. Virol. 69 1995 3878 3884
58. G. Zybarth, H.-G. Kräusslich, K. Partin, and C. Carter Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain J. Virol. 68 1994 240 250